Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jungyeon Hwang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Bioactive Compounds|November 15, 2011
CRLX101 (formerly IT-101)-A Novel Nanopharmaceutical of Camptothecin in Clinical DevelopmentCissy Young, Thomas Schluep, Jungyeon Hwang, et al.
Chemical Communications (Cambridge, England)|August 31, 2007
Reactive block copolymer scaffoldsRonald C Li, Jungyeon Hwang, Heather D Maynard
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 30, 2007
Well-defined polymers with activated ester and protected aldehyde side chains for bio-functionalizationJungyeon Hwang, Ronald C Li, Heather D Maynard
International Journal of Nanomedicine|November 11, 2008
Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapyJungyeon Hwang, Kathleen Rodgers, James C Oliver, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 20, 2009
Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomasDarya Alizadeh, Leying Zhang, Jungyeon Hwang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2011
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101Sonke Svenson, Marc Wolfgang, Jungyeon Hwang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2009
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurementsThomas Schluep, Jungyeon Hwang, Isabel J Hildebrandt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 3, 2023
Volumetric imaging of optically cleared and fluorescently labeled animal tissue (VIOLA) for quantifying the 3D biodistribution of nanoparticles at cellular resolution in tumor tissueNikolai Rakhilin, Bing Yang, Mary E Spilker, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticleScott Eliasof, Douglas Lazarus, Christian G Peters, et al.
Molecular Pharmaceutics|February 3, 2016
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric NanopharmaceuticalSonke Svenson, Roy I Case, Roderick O Cole, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Bioactive Compounds|November 15, 2011
CRLX101 (formerly IT-101)-A Novel Nanopharmaceutical of Camptothecin in Clinical DevelopmentCissy Young, Thomas Schluep, Jungyeon Hwang, et al.
Chemical Communications (Cambridge, England)|August 31, 2007
Reactive block copolymer scaffoldsRonald C Li, Jungyeon Hwang, Heather D Maynard
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 30, 2007
Well-defined polymers with activated ester and protected aldehyde side chains for bio-functionalizationJungyeon Hwang, Ronald C Li, Heather D Maynard
International Journal of Nanomedicine|November 11, 2008
Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapyJungyeon Hwang, Kathleen Rodgers, James C Oliver, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 20, 2009
Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomasDarya Alizadeh, Leying Zhang, Jungyeon Hwang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2011
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101Sonke Svenson, Marc Wolfgang, Jungyeon Hwang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2009
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurementsThomas Schluep, Jungyeon Hwang, Isabel J Hildebrandt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 3, 2023
Volumetric imaging of optically cleared and fluorescently labeled animal tissue (VIOLA) for quantifying the 3D biodistribution of nanoparticles at cellular resolution in tumor tissueNikolai Rakhilin, Bing Yang, Mary E Spilker, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticleScott Eliasof, Douglas Lazarus, Christian G Peters, et al.
Molecular Pharmaceutics|February 3, 2016
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric NanopharmaceuticalSonke Svenson, Roy I Case, Roderick O Cole, et al.
Pageof 2